I’ve been reflecting on how critical it is for us to stay vigilant about adverse event reporting in clinical trials. Recently, I came across data indicating that nearly 30% of reported adverse events go unaddressed, which raises serious safety concerns. How is everyone else approaching risk management in their studies?
It’s wild to think that nearly one-third of adverse events just slip through the cracks — like a sock in a dryer! I try to make sure our team has regular check-ins to review these reports, making it less likely they get overlooked. How do you track those events in your studies? @JaneDoe.
I completely agree on the importance of tracking adverse events. We’ve started using dedicated software to streamline the reporting process and ensure nothing slips through. How often do you think teams should review these reports to stay proactive?
It really makes you think about the tools we use. I’ve found that having a real-time dashboard for tracking issues helps the team spot patterns before they escalate, especially considering that nearly 30% of cases get neglected. @micwalk, have you tried any specific software that integrates well with your current system?
I’ve found that having a dedicated role focused solely on monitoring safety reports can really help address those unaddressed cases. It keeps things organized and responsive, especially when you’re juggling multiple studies. Curious if anyone else has tried assigning specific team members for this purpose?